Novartis’ Kisqali plus endocrine therapy shows significant PFS benefits in advanced breast cancer trials
Swiss pharmaceutical giant Novartis has announced that its breast cancer drug, Kisqali (ribociclib), when used in combination with endocrine therapy, has demonstrated substantial efficacy in ... Read More
Oncternal Therapeutics launches Phase 1b trial of Cirmtuzumab in combination with Paclitaxel in breast cancer
Oncternal Therapeutics, a leading U.S. oncology company, has announced the dosing of the first patient in a phase 1b trial of its investigational drug cirmtuzumab, ... Read More
EVA smart bra developed to detect early signs of breast cancer
An all new smart bra dubbed as EVA Smart Bra has been developed by a Mexican teenager that can potentially be a life saver for ... Read More
Five Reasons Why You Should Take Off Your Bra Before Sleeping
Did you ever wonder whether sleeping with your bra on can create problems for you? Then, you are right, experts are advising to take off ... Read More
Cannabis oil benefits breast cancer | Cannabis oil for cancer treatment in India
As per the latest research reports, it was found that cannabis oil compounds are capable of killing malignant cells of cancer. Cannabis is used as ... Read More
Lilly’s breast cancer drug abemaciclib shows promising results in phase 3 trial
Indianapolis-based pharmaceutical giant Lilly has announced positive outcomes from its phase 3 clinical trial, MONARCH 2, involving its innovative breast cancer treatment, abemaciclib, in combination ... Read More
Roche’s Perjeta shows significant promise in phase 3 breast cancer trial
Roche has announced promising results from the APHINITY trial, a crucial Phase 3 study evaluating Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy. This ... Read More
University of Antwerp launches pioneering clinical trial to combat cognitive deficits in breast cancer patients
The University of Antwerp in Belgium has initiated an innovative clinical trial aimed at mitigating the cognitive deficits associated with breast cancer treatment, marking a ... Read More